Genetic risk for co‐occurrence of type 1 diabetes and celiac disease is modified by<scp>HLA</scp>‐C and killer immunoglobulin‐like receptors
Darja Šmigoc Schweiger(Ljubljana University Medical Centre), Blanka Vidan‐Jeras(Blood Transfusion Centre of Slovenia), Nataša Bratina(Ljubljana University Medical Centre), Tadej Battelino(University of Ljubljana), Jernej Brecelj(University of Ljubljana), Andrijana Mendez(Blood Transfusion Centre of Slovenia), Nevenka Bratanič(Ljubljana University Medical Centre), Sabina Kunilo Jamnik(Blood Transfusion Centre of Slovenia)
Cited by 21
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k
Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration study
|Diabetologia|2018|516
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
|Journal of Diabetes Science and Technology|2022|288
Genotype correlates with the natural history of severe bile salt export pump deficiency
|Journal of Hepatology|2020|133